FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080628209> ?p ?o ?g. }

• W2080628209 endingPage "78" @default.
• W2080628209 startingPage "78" @default.
• W2080628209 abstract "Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is common, but trial evidence is conflicting and therapeutic options are controversial.To conduct a systematic review and network meta-analysis comparing mean symptom scores and treatment response among α-blockers, antibiotics, anti-inflammatory drugs, other active drugs (phytotherapy, glycosaminoglycans, finasteride, and neuromodulators), and placebo.We searched MEDLINE from 1949 and EMBASE from 1974 to November 16, 2010, using the PubMed and Ovid search engines.Randomized controlled trials comparing drug treatments in CP/CPPS patients.Two reviewers independently extracted mean symptom scores, quality-of-life measures, and response to treatment between treatment groups. Standardized mean difference and random-effects methods were applied for pooling continuous and dichotomous outcomes, respectively. A longitudinal mixed regression model was used for network meta-analysis to indirectly compare treatment effects.Twenty-three of 262 studies identified were eligible. Compared with placebo, α-blockers were associated with significant improvement in symptoms with standardized mean differences in total symptom, pain, voiding, and quality-of-life scores of -1.7 (95% confidence interval [CI], -2.8 to -0.6), -1.1 (95% CI, -1.8 to -0.3), -1.4 (95% CI, -2.3 to -0.5), and -1.0 (95% CI, -1.8 to -0.2), respectively. Patients receiving α-blockers or anti-inflammatory medications had a higher chance of favorable response compared with placebo, with pooled RRs of 1.6 (95% CI, 1.1-2.3) and 1.8 (95% CI, 1.2-2.6), respectively. Contour-enhanced funnel plots suggested the presence of publication bias for smaller studies of α-blocker therapies. The network meta-analysis suggested benefits of antibiotics in decreasing total symptom scores (-9.8; 95% CI, -15.1 to -4.6), pain scores (-4.4; 95% CI, -7.0 to -1.9), voiding scores (-2.8; 95% CI, -4.1 to -1.6), and quality-of-life scores (-1.9; 95% CI, -3.6 to -0.2) compared with placebo. Combining α-blockers and antibiotics yielded the greatest benefits compared with placebo, with corresponding decreases of -13.8 (95% CI, -17.5 to -10.2) for total symptom scores, -5.7 (95% CI, -7.8 to -3.6) for pain scores, -3.7 (95% CI, -5.2 to -2.1) for voiding, and -2.8 (95% CI, -4.7 to -0.9) for quality-of-life scores.α-Blockers, antibiotics, and combinations of these therapies appear to achieve the greatest improvement in clinical symptom scores compared with placebo. Anti-inflammatory therapies have a lesser but measurable benefit on selected outcomes. However, beneficial effects of α-blockers may be overestimated because of publication bias." @default.
• W2080628209 created "2016-06-24" @default.
• W2080628209 creator A5025744752 @default.
• W2080628209 creator A5034811772 @default.
• W2080628209 creator A5043144062 @default.
• W2080628209 creator A5053331577 @default.
• W2080628209 creator A5056464791 @default.
• W2080628209 creator A5069295759 @default.
• W2080628209 creator A5073349870 @default.
• W2080628209 date "2011-01-05" @default.
• W2080628209 modified "2023-09-30" @default.
• W2080628209 title "Management of Chronic Prostatitis/ Chronic Pelvic Pain Syndrome" @default.
• W2080628209 cites W1514079823 @default.
• W2080628209 cites W1554040650 @default.
• W2080628209 cites W1572187112 @default.
• W2080628209 cites W1592602394 @default.
• W2080628209 cites W1594342281 @default.
• W2080628209 cites W1965310222 @default.
• W2080628209 cites W1967385770 @default.
• W2080628209 cites W1973214716 @default.
• W2080628209 cites W1978638209 @default.
• W2080628209 cites W1988246107 @default.
• W2080628209 cites W1988988586 @default.
• W2080628209 cites W1989945905 @default.
• W2080628209 cites W1994459308 @default.
• W2080628209 cites W1997517088 @default.
• W2080628209 cites W2017394538 @default.
• W2080628209 cites W2026467462 @default.
• W2080628209 cites W2027766463 @default.
• W2080628209 cites W2032095501 @default.
• W2080628209 cites W2036792996 @default.
• W2080628209 cites W2037558979 @default.
• W2080628209 cites W2043656701 @default.
• W2080628209 cites W2048919660 @default.
• W2080628209 cites W2058651188 @default.
• W2080628209 cites W2058839924 @default.
• W2080628209 cites W2061633878 @default.
• W2080628209 cites W2061918531 @default.
• W2080628209 cites W2062279942 @default.
• W2080628209 cites W2068659661 @default.
• W2080628209 cites W2076617109 @default.
• W2080628209 cites W2077215956 @default.
• W2080628209 cites W2078397510 @default.
• W2080628209 cites W2084533806 @default.
• W2080628209 cites W2092844578 @default.
• W2080628209 cites W2093424875 @default.
• W2080628209 cites W2093843028 @default.
• W2080628209 cites W2093948837 @default.
• W2080628209 cites W2097441503 @default.
• W2080628209 cites W2099764406 @default.
• W2080628209 cites W2102951421 @default.
• W2080628209 cites W2103646177 @default.
• W2080628209 cites W2113144077 @default.
• W2080628209 cites W2114923113 @default.
• W2080628209 cites W2130658763 @default.
• W2080628209 cites W2135578992 @default.
• W2080628209 cites W2140699272 @default.
• W2080628209 cites W2143209686 @default.
• W2080628209 cites W2149820490 @default.
• W2080628209 cites W2156753060 @default.
• W2080628209 cites W2167757606 @default.
• W2080628209 cites W2399965866 @default.
• W2080628209 cites W2412606745 @default.
• W2080628209 cites W3025369505 @default.
• W2080628209 cites W349241224 @default.
• W2080628209 cites W3028061837 @default.
• W2080628209 doi "https://doi.org/10.1001/jama.2010.1913" @default.
• W2080628209 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21205969" @default.
• W2080628209 hasPublicationYear "2011" @default.
• W2080628209 type Work @default.
• W2080628209 sameAs 2080628209 @default.
• W2080628209 citedByCount "212" @default.
• W2080628209 countsByYear W20806282092012 @default.
• W2080628209 countsByYear W20806282092013 @default.
• W2080628209 countsByYear W20806282092014 @default.
• W2080628209 countsByYear W20806282092015 @default.
• W2080628209 countsByYear W20806282092016 @default.
• W2080628209 countsByYear W20806282092017 @default.
• W2080628209 countsByYear W20806282092018 @default.
• W2080628209 countsByYear W20806282092019 @default.
• W2080628209 countsByYear W20806282092020 @default.
• W2080628209 countsByYear W20806282092021 @default.
• W2080628209 countsByYear W20806282092022 @default.
• W2080628209 countsByYear W20806282092023 @default.
• W2080628209 crossrefType "journal-article" @default.
• W2080628209 hasAuthorship W2080628209A5025744752 @default.
• W2080628209 hasAuthorship W2080628209A5034811772 @default.
• W2080628209 hasAuthorship W2080628209A5043144062 @default.
• W2080628209 hasAuthorship W2080628209A5053331577 @default.
• W2080628209 hasAuthorship W2080628209A5056464791 @default.
• W2080628209 hasAuthorship W2080628209A5069295759 @default.
• W2080628209 hasAuthorship W2080628209A5073349870 @default.
• W2080628209 hasConcept C121608353 @default.
• W2080628209 hasConcept C126322002 @default.
• W2080628209 hasConcept C142724271 @default.
• W2080628209 hasConcept C168563851 @default.
• W2080628209 hasConcept C17744445 @default.
• W2080628209 hasConcept C199539241 @default.

• next